loadpatents
name:-0.016693115234375
name:-0.013401985168457
name:-0.012027025222778
Wu; Frank Xinhe Patent Filings

Wu; Frank Xinhe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Frank Xinhe.The latest application filed is for "inhibitors of protease-activated receptor-2".

Company Profile
12.14.15
  • Wu; Frank Xinhe - Waltham MA
  • Wu; Frank Xinhe - Shrewsbury MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors of protease-activated receptor-2
Grant 10,995,072 - Cumming , et al. May 4, 2
2021-05-04
Inhibitors Of Protease-activated Receptor-2
App 20200140392 - Cumming; John Graham ;   et al.
2020-05-07
Metabotrophic glutamate receptor 5 modulators and methods use thereof
Grant 10,640,510 - Heffernan , et al.
2020-05-05
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20200079778 - Heffernan; Michele L.R. ;   et al.
2020-03-12
Inhibitors of protease-activated receptor-2
Grant 10,550,089 - Cumming , et al. Fe
2020-02-04
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 10,533,000 - Heffernan , et al. Ja
2020-01-14
Inhibitors Of Protease-activated Receptor-2
App 20190144394 - Cumming; John Graham ;   et al.
2019-05-16
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20190135815 - Heffernan; Michele L.R. ;   et al.
2019-05-09
Compounds For Treating Disorders Mediated By Metabotropic Glutamate Receptor 5, And Methods Of Use Thereof
App 20190055204 - Hardy; Larry Wendell ;   et al.
2019-02-21
Metabotrophic glutamate receptor 5 modulators and methods use thereof
Grant 10,196,399 - Heffernan , et al. Fe
2019-02-05
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
Grant 10,077,243 - Hardy , et al. September 18, 2
2018-09-18
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20180037585 - Heffernan; Michele L.R. ;   et al.
2018-02-08
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 9,708,331 - Heffernan , et al. July 18, 2
2017-07-18
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20160251359 - Heffernan; Michele L.R. ;   et al.
2016-09-01
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 9,260,452 - Heffernan , et al. February 16, 2
2016-02-16
Compounds For Treating Disorders Mediated By Metabotropic Glutamate Receptor 5, And Methods Of Use Thereof
App 20140349992 - Hardy; Larry Wendell ;   et al.
2014-11-27
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20140221332 - Heffernan; Michele L. R. ;   et al.
2014-08-07
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
Grant 8,772,301 - Hardy , et al. July 8, 2
2014-07-08
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20140179682 - Heffernan; Michele L. R. ;   et al.
2014-06-26
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
App 20130289013 - FANG; Qun Kevin ;   et al.
2013-10-31
Imidazo[1,2-a]pyridine compounds
Grant 8,497,278 - Fang , et al. July 30, 2
2013-07-30
Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof
App 20110319380 - Hardy; Larry Wendell ;   et al.
2011-12-29
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
App 20110166146 - Fang; Qun Kevin ;   et al.
2011-07-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed